Cernostics
Danville
About Cernostics
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.3M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2021)
- Website: cernostics.com
- Phone: (570)214-5123
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cernostics-1185 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.